Skip to content
healthcare.dev

Cholestyramine

NDC 42571-508, Cholestyramine, powder, for suspension, from Micro Labs Limited.

Product NDC
42571-508
Status
Listed
Labeler
Micro Labs Limited
Dosage form
POWDER, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219318
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/42571-508 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CHOLESTYRAMINE4 g/9g

Pharmacologic classes

Bile Acid Sequestrant [EPC]; Bile-acid Binding Activity [MoA]

Package NDCNDC-11Package
42571-508-294257105082960 POUCH in 1 CARTON (42571-508-29) / 9 g in 1 POUCH (42571-508-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/09420793-7357-4194-8172-0b1cddb167fe
  • NADAC price for package 42571050829

    GET /v1/drugs/nadac/42571050829

Use it

Look up 42571-508 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/42571-508 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 42571-508. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.